ARWR
Price
$13.25
Change
+$0.19 (+1.45%)
Updated
May 8 closing price
Capitalization
1.79B
3 days until earnings call
NRIX
Price
$9.64
Change
+$0.34 (+3.66%)
Updated
May 8 closing price
Capitalization
734.91M
62 days until earnings call
Ad is loading...

ARWR vs NRIX

Header iconARWR vs NRIX Comparison
Open Charts ARWR vs NRIXBanner chart's image
Arrowhead Pharmaceuticals
Price$13.25
Change+$0.19 (+1.45%)
Volume$1.29M
Capitalization1.79B
Nurix Therapeutics
Price$9.64
Change+$0.34 (+3.66%)
Volume$1.08M
Capitalization734.91M
ARWR vs NRIX Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. NRIX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Hold and NRIX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ARWR: $13.25 vs. NRIX: $9.64)
Brand notoriety: ARWR: Notable vs. NRIX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 72% vs. NRIX: 102%
Market capitalization -- ARWR: $1.79B vs. NRIX: $734.91M
ARWR [@Biotechnology] is valued at $1.79B. NRIX’s [@Biotechnology] market capitalization is $734.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, ARWR is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 6 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • ARWR’s TA Score: 6 bullish, 2 bearish.
  • NRIX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ARWR is a better buy in the short-term than NRIX.

Price Growth

ARWR (@Biotechnology) experienced а -5.63% price change this week, while NRIX (@Biotechnology) price change was -13.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

ARWR is expected to report earnings on Aug 11, 2025.

NRIX is expected to report earnings on Jul 10, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($1.79B) has a higher market cap than NRIX($735M). ARWR YTD gains are higher at: -29.521 vs. NRIX (-48.832). NRIX has higher annual earnings (EBITDA): -214M vs. ARWR (-580.69M). ARWR (553M) and NRIX (550M) have equal amount of cash in the bank . NRIX has less debt than ARWR: NRIX (26.6M) vs ARWR (525M). NRIX has higher revenues than ARWR: NRIX (56.4M) vs ARWR (2.5M).
ARWRNRIXARWR / NRIX
Capitalization1.79B735M244%
EBITDA-580.69M-214M271%
Gain YTD-29.521-48.83260%
P/E RatioN/AN/A-
Revenue2.5M56.4M4%
Total Cash553M550M101%
Total Debt525M26.6M1,974%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRNRIX
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WEQCX9.58N/A
N/A
TETON Westwood Equity C
PPQJX3.33N/A
N/A
Principal MidCap Growth III J
FPACX40.54N/A
N/A
FPA Crescent
TRREX11.44N/A
N/A
T. Rowe Price Real Estate
VSCRX53.24N/A
N/A
Virtus KAR Small-Cap Core R6

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+1.45%
DNLI - ARWR
56%
Loosely correlated
+0.77%
RGNX - ARWR
54%
Loosely correlated
-1.24%
NTLA - ARWR
54%
Loosely correlated
+13.58%
BEAM - ARWR
52%
Loosely correlated
+6.32%
VERV - ARWR
50%
Loosely correlated
+6.16%
More